Companies: 10,795·Total market cap: $144.5T
Canntab Therapeutics Limited

Canntab Therapeutics Limited

CTABFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$3891
P/E Ratio
52W High$0.0073
52W Low$0.0001
Overview

Canntab Therapeutics Limited(CTABF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CTABF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.09ctabf eps ttm · ctabf earnings per shareEarnings history
PE Ratio (TTM)ctabf pe ratio ttm · ctabf price to earningsPE Ratio deep dive
Revenue (TTM)73477.00ctabf revenue ttm · ctabf annual revenueFull revenue history
Dividend Yield33.54%does ctabf pay dividends · ctabf dividend yieldDividend history
Shares Outstanding37.7Mctabf shares outstanding · ctabf floatShares outstanding history
Next EarningsTBActabf earnings date · ctabf next earningsEarnings history

财务快照

完整财报
FY 2022Revenue$293362.00
202020212022
canntab therapeutics limited revenue · ctabf revenue 2022
FY 2022Net Income-$3.7M▲ +16.53% YoY
202020212022
canntab therapeutics limited net income · ctabf profit 2022
FY 2022EPS$-0.10▲ +24.77% YoY
202020212022
ctabf eps · canntab therapeutics limited earnings per share 2022
TTM:Revenue: $73477.00Net Income: -$3.4MEPS: $-0.09View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-99.99%

关于 Canntab Therapeutics Limited

CEORichard C. Goldstein
IPO DateNov 28, 2017
Employees
CountryCA
Websitecanntab.ca

Canntab Therapeutics Limited is a Canadian phytopharmaceutical firm dedicated to pioneering the research and development of sophisticated, pharmaceutical-grade cannabinoid preparations. The company ma…

what is canntab therapeutics limited · ctabf stock overview · canntab therapeutics limited company profile · who is canntab therapeutics limited ceo · ctabf OTC · canntab therapeutics limited headquarters · canntab therapeutics limited business segments

关于股票概览与关键数据

Canntab Therapeutics Limited(CTABF)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Nov 28, 2017 在 OTC 上市。截至最近交易日,CTABF 股价为 $0.00,市值约为 $3,891。过去12个月累计回报 +0.00%,年初至今回报 +0.00%。

2022 财年 Canntab Therapeutics Limited 营收 $293362.00。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Canntab Therapeutics Limited(CTABF)股价为 $0.00,在 OTC 上市,52周区间为 $0.00 – $0.01。

CTABF 最新股价CTABF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议